Effectiveness of preimplantation genetic testing in sickle cell disease: insights from a single-center experience
PGT-M is as a viable option for obtaining healthy offspring. These results bolster the argument that PGT-M serves as an alternative to prenatal diagnosis for eligible couples. Our study aims to assist geneticists, gynecologists, and hematologists in providing the necessary guidance before embarking couples on this long and often challenging journey.
Authors
- Anne Mayeur (ORCID: https://orcid.org/0000-0002-5764-5382)
- Julie Steffann (ORCID: https://orcid.org/0000-0001-5259-4144)
- Nathalie Frydman
- Charlotte Sonigo (ORCID: https://orcid.org/0000-0002-0875-1592)
- Fatoumata Souaré
- H. Thomas
- S. Monnot
- A. Habibi
- M. Grynberg
- L. Joseph
- A. Aganahi
- A. Benachi
Institutions
- Hôpital Necker-Enfants Malades (FR)
- Inserm (FR)
- Université Paris-Saclay (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Antoine-Béclère (FR)
- Biologie intégrée du globule rouge et de l'Erythropoïèse (FR)
- Institut Mondor de Recherche Biomédicale (FR)
Publication Details
- Journal
- Journal of Assisted Reproduction and Genetics
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1007/s10815-026-03809-1
- Primary Topic
- Prenatal Screening and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00